Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells
Controlling transgene expression through an externally administered inductor is envisioned as a potent strategy to improve safety and efficacy of gene therapy approaches. Generally, inducible ON systems require a chimeric transcription factor (transactivator) that becomes activated by an inductor, w...
Saved in:
Main Authors: | María Tristán-Manzano (Author), Noelia Maldonado-Pérez (Author), Pedro Justicia-Lirio (Author), Marina Cortijo-Gutierréz (Author), Pablo Tristán-Ramos (Author), Carlos Blanco-Benítez (Author), Kristina Pavlovic (Author), Araceli Aguilar-González (Author), Pilar Muñoz (Author), Francisco J. Molina-Estevez (Author), Valerie Griesche (Author), Juan Antonio Marchal (Author), Sara R. Heras (Author), Karim Benabdellah (Author), Francisco Martin (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improved Functionality of Integration-Deficient Lentiviral Vectors (IDLVs) by the Inclusion of IS<sub>2</sub> Protein Docks
by: Marina Cortijo-Gutiérrez, et al.
Published: (2021) -
First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas
by: Pedro Justicia-Lirio, et al.
Published: (2024) -
The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes
by: Sabina Sánchez-Hernández, et al.
Published: (2018) -
Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges
by: Eduardo Martínez-Molina, et al.
Published: (2020) -
Lentiviral Vectors for Ocular Gene Therapy
by: Yvan Arsenijevic, et al.
Published: (2022)